Navigation Links
Inverness Medical Innovations Announces Third Quarter 2009 Results
Date:10/27/2009

tock equivalent shares from the potential conversion of Series B convertible preferred stock for the nine months ended September 30, 2008 were not used in the calculation of diluted net income per common share, on an adjusted cash basis, because inclusion thereof would be antidilutive.


               Inverness Medical Innovations, Inc. and Subsidiaries
                      Condensed Consolidated Balance Sheets
                                    (in $000s)

                                                   September 30, December 31,
                                                            2009         2008
    ASSETS
    CURRENT ASSETS:
    Cash and cash equivalents                           $555,871     $141,324
    Restricted cash                                        3,098        2,748
    Marketable securities                                    907        1,763
    Accounts receivable, net                             363,054      280,608
    Inventories, net                                     223,103      199,131
    Prepaid expenses and other current assets            169,370      196,969
    Total current assets                               1,315,403      822,543

    PROPERTY, PLANT AND EQUIPMENT, NET                   324,020      284,483
    GOODWILL AND OTHER INTANGIBLE ASSETS, NET          5,188,346    4,717,704
    DEFERRED FINANCING COSTS AND OTHER ASSETS, NET       154,332      130,630
    Total assets                                      $6,982,101   $5,955,360

    LIABILITIES AND STOCKHOLDERS' EQUITY

    CURRENT LIABILITIES:
    Current portion of notes payable                     $19,612      $19,509
    Other current liabilities                            450,311      345,836
    Total current liabilities                            469,923      365,345

    LONG-TERM LIABILITIES:
    Notes payable, net of current portion              2,134,398    1,501,025
    Deferred tax liabilities                             506,074      46
'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimers Disease
2. Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
3. Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit
4. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
5. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
6. Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR
7. Reportlinker Adds Medical Devices & Equipment in India (2009)
8. ATS Medical Announces Third Quarter 2009 Earnings Release Date and Conference Call
9. Rcadia Medical Imaging Wins 2009 AuntMinnie.com Best New Radiology Vendor Award
10. Cardio Vascular Medical Device Sends Update to Shareholders
11. Symmetry Medical Updates Full Year 2009 Financial Guidance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire-FirstCall/--AnadysPharmaceuticals,Inc.(Nasda...nnualPiperJaffrayHealthcareConferenceonTuesday,Dec...eisbeingheldatTheNewYorkPalaceHotel.SteveWorland,P...lprovideanoverviewofAnadysanditsclinicaldevelopmen...ntationwillbesimultaneouslywebcastandcanbeaccessed...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--ThoratecCorporation(Nas...rculatorysupporttherapiestosave,supportandrestoref...he21stAnnualPiperJaffrayHealthCareConferenceonTues...sidentandchieffinancialofficer,willprovideanupdate...me(5:30a.m.,PacificStandardTime). ,, Thepresent...
(Date:11/24/2009)...RNewswire/--PharmaceuticalInstitute,aleadingprovid...alandbiotechindustry,todayannouncedthelaunchofanew...alMarketplace e-courseisthenewestadditiontothecomp...ensiveseriesofe-coursesdesignedtofillthecriticalne...mercialprofessionals. ,, Thenewthreemodule Hosp...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 1Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 2Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 3Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 4Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 5Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 6Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 7Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 8Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 9Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 10Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 11Ratcliff Promotes Jorge Burbano to Senior Associate 3B Tess Kavanagh and Tony Keung to Associate 12477 1Ratcliff Promotes Jorge Burbano to Senior Associate 3B Tess Kavanagh and Tony Keung to Associate 12477 2Cambrex Regains Compliance With Revised NYSE Listing Standards 47999 1
...rs at Brigham and Women,s,Hospital found that pati...getting "high," but these effects were unrelated t...ir study, one of the first to examine the addictiv...resented today at the American,Academy of Pain Med...jay Wasan, MD MSc and colleagues found that when u...
...sts Leading Major Study into Lethal ,Super, Strain...ish Midlands Development Corporation today announc... are leading a major European study to unravel the... hospital acquired infections. , , The $4.5 milli...ology developed in Nottingham to study the functio...
Other Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 3
(Date:11/25/2009)...Newswire/-SentinelleMedicalInc.,aleadingmanufactur...ndCalgaryScientificInc.,aleadingproviderofsoftware...gis(TM)Breast4DAdvancedVisualizationsoftware. ,...rintWebclientbasedmedicalimagingofferinginthemarke...ero-footprintaccess-requiringnosoftwaredownload,an...
(Date:11/25/2009)...e-USNewswire/--TheBlackAIDSInstituterecentlyheldBo...ipfor2010. ,, ThenewBoardMembersareahighlydiver...finance,governmenthealthprograms,editorial,andbusi...geofpersonalbackgroundsincludingbothheterosexualan...ndrepresentingmultipleagegroups. ,, (Photo: htt...
(Date:11/25/2009)...f a statistically significant survival benefit fro... receptor (ER)-positive tumors had high levels of ...ha S118-P), according to a brief communication pub...ational Cancer Institute . , Approximately 50% o...eclinical studies have shown that ER-alpha S118-P ...
(Date:11/25/2009)...eumatoid arthritis, could help newly diagnosed dia...25 (HealthDay News) -- A drug commonly used to tre... now also shows some promise in helping patients n..., rituximab (Rituxan), helped patients keep produc...ease had destroyed some of their pancreatic beta c...
(Date:11/25/2009)... signs of trouble with the H1N1 vaccine, , ...ngoing H1N1 swine flu pandemic may be driving a re...atients, a U.S. health official said Wednesday. ,...cal infections around the country," Dr. Anne Schuc...ion and Respiratory Diseases at the U.S. Centers f...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
... Dec. 17 Erica Frank, a medical doctor and,resear...eves people anywhere in,the world working to remed...e,best medical information - not just those who ha... Frank,s idea led her to develop Health Sciences O...
...oosts survival, even when tumor is linked to hepat... 16 (HealthDay News) -- The drug sorafenib increas... advanced liver cancer, according to the results o...(Nexavar) twice a day in six-week cycles, while th...
... Dec. 17 The LCA-Vision Full Value Committee,comp...d Alan H. Buckey, today,announced that it has sent...NasdaqGS: LCAV). The members of The LCA-Vision Ful... from the LCA-Vision Full Value Committee, ATTE...
...ntments continue to strengthen diagnostics product... Dec. 17 HistoRx, Inc., announced today that it h...d position of Vice President, Diagnostics Marketin...e diagnostics and pharmaceuticals industries. Befo...
... GlaxoSmithKline (LSE:GSK) (NYSE:GS...AX) today announced a worldwide strategic alliance...bitors of endosomal Toll-like Receptors (TLRs) for... LONDON & PHILADELPHIA & BE...
... Independent Living Aids (ila) is p...ucts in the blindness and visual impairment field....ve Voice Responsive Clock, is a natural addition t... Aids (ila) is proud to be the exclusive distribut...
Other Medicine News:Health News:Vivisimo Search Delivers Medical Knowledge to Global Health-Care Community 2Health News:Drug Helps Asians Battling Liver Cancer 2Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 2Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 3Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 4Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 5Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 6Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 7Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 8Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 9Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 10Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 11Health News:HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor 2Health News:HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor 3Health News: GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases – 2Health News: GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases – 3Health News: GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases – 4Health News:Moshi Names Independent Living Aids Exclusive Distributor in Blindness and Visual Impairment Field 2Health News:Moshi Names Independent Living Aids Exclusive Distributor in Blindness and Visual Impairment Field 3
Stainless Steel Flexible Ruler
Sinuscope. A4.0AE70
Sinuscope. A4.0AE30
Sinuscope. A1.8AE30
Medicine Products: